(Q39534782)

12 September 2017

title

HIV-protease inhibitors block the replication of both vesicular stomatitis and influenza viruses at an early post-entry replication step (English)

1 reference

12 September 2017

1 reference

Maurizio Federico

1

1 reference

12 September 2017

language of work or name

English

0 references

publication date

28 May 2011

1 reference

12 September 2017

number of pages

13

1 reference

inferred from page(s)

published in

Virology

1 reference

12 September 2017

volume

417

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

37-49

1 reference

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

In vitro and in vivo effects of HIV protease inhibitors on apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Identification of host proteins required for HIV infection through a functional genomic screen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Identification of host factors involved in borna disease virus cell entry through a small interfering RNA functional genetic screen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Inhibition of human preadipocyte proteasomal activity by HIV protease inhibitors or specific inhibitor lactacystin leads to a defect in adipogenesis, which involves matrix metalloproteinase-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

An HIV protease inhibitor, ritonavir targets the nuclear factor-kappaB and inhibits the tumor growth and infiltration of EBV-positive lymphoblastoid B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

7 January 2021

HIV-protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

In vitro and in vivo activities of anti-influenza virus compound T-705.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

A new reporter cell line to monitor HIV infection and drug susceptibility in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Drosophila RNAi screen identifies host genes important for influenza virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Activation of influenza A viruses by trypsin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

RNA interference screen for human genes associated with West Nile virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Generation and characterization of a stable cell population releasing fluorescent HIV-1-based Virus Like Particles in an inducible way.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Human immunodeficiency virus type 1 (HIV-1) protease inhibitors block cell-to-cell HIV-1 endocytosis in dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Different effect of proteasome inhibition on vesicular stomatitis virus and poliovirus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

"UnPAKing" human immunodeficiency virus (HIV) replication: using small interfering RNA screening to identify novel cofactors and elucidate the role of group I PAKs in HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Expanding the frontiers of existing antiviral drugs: possible effects of HIV-1 protease inhibitors against SARS and avian influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Structured model of influenza virus replication in MDCK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Modeling the viral dynamics of influenza A virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Role of hemagglutinin cleavage for the pathogenicity of influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Biochemistry. Viral glycoproteins and an evolutionary conundrum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

Vesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

7 January 2021

inferred from DOI database lookup

Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.002

7 January 2021

inferred from DOI database lookup

Mechanism of interferon action: inhibition of vesicular stomatitis virus replication in human amnion U cells by cloned human leukocyte interferon. I. Effect on early and late stages of the viral multiplication cycle

1 reference

12 December 2020

Effect of repeated inoculation of interferon preparations on infection of mice with encephalomyocarditis virus

1 reference

12 December 2020

Transcription and replication of nonsegmented negative-strand RNA viruses.

1 reference

12 December 2020

The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.

1 reference

12 December 2020

10.1016/J.VIROL.2011.05.002

Identifiers

DOI

1 reference

release_asqkpghqgze7xm6vjmeirl2qba

12 September 2017

Fatcat ID

0 references

PMC publication ID

7111985

0 references

1 reference